Search Results - "OPIE, LIONEL H"

Refine Results
  1. 1

    Metabolic mechanisms in heart failure by ASHRAFIAN, Houman, FRENNEAUX, Michael P, OPIE, Lionel H

    Published in Circulation (New York, N.Y.) (24-07-2007)
    “…Although neurohumoral antagonism has successfully reduced heart failure morbidity and mortality, the residual disability and death rate remains unacceptably…”
    Get full text
    Journal Article
  2. 2

    The Adrenergic-Fatty Acid Load in Heart Failure by Opie, Lionel H., MD, DPhil, DSc, Knuuti, Juhani, MD, PhD

    “…The hypothesis proposed is that heart failure (HF) is associated with a reactive hyperadrenergic state that increases circulating plasma free fatty acids…”
    Get full text
    Journal Article
  3. 3

    Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway by Lacerda, Lydia, Somers, Sarin, Opie, Lionel H., Lecour, Sandrine

    Published in Cardiovascular research (01-11-2009)
    “…Aims Ischaemic postconditioning (IPostC) is a powerful protective phenomenon that activates prosurvival intrinsic signalling cascades to limit reperfusion…”
    Get full text
    Journal Article
  4. 4

    Role of toll-like receptor 4 in melatonin-induced cardioprotection by Nduhirabandi, Frederic, Lamont, Kim, Albertyn, Zulfah, Opie, Lionel H., Lecour, Sandrine

    Published in Journal of pineal research (01-01-2016)
    “…Melatonin protects the heart against myocardial ischemia/reperfusion injury via the activation of the survivor activating factor enhancement (SAFE) pathway…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy by TUUNANEN, Helena, ENGBLOM, Erik, OPIE, Lionel H, KNUUTI, Juhani, NAUM, Alexandru, NAGREN, Kjell, SCHEININ, Mika, HESSE, Birger, JUHANI AIRAKSINEN, K. E, NUUTILA, Pirjo, IOZZO, Patricia, UKKONEN, Heikki

    Published in Circulation (New York, N.Y.) (16-09-2008)
    “…The anti-ischemic agent trimetazidine improves ejection fraction in heart failure that is hypothetically linked to inhibitory effects on cardiac free fatty…”
    Get full text
    Journal Article
  7. 7

    Present status of statin therapy by Opie, Lionel H., MD, DPhil

    Published in Trends in cardiovascular medicine (01-04-2015)
    “…Abstract Statins are cardioprotective agents that reduce the adverse effects of increased low-density lipoprotein cholesterol (LDL-C) levels. For significantly…”
    Get full text
    Journal Article
  8. 8

    Role of melatonin, melatonin receptors and STAT3 in the cardioprotective effect of chronic and moderate consumption of red wine by Lamont, Kim, Nduhirabandi, Frederic, Adam, Tasneem, Thomas, D. Paul, Opie, Lionel H., Lecour, Sandrine

    “…We have recently discovered that melatonin, given acutely and directly to the isolated heart at the concentration found in wine, confers cardioprotection…”
    Get full text
    Journal Article
  9. 9

    A Proposal to Incorporate Trial Data Into a Hybrid American College of Cardiology/American Heart Association Algorithm for the Allocation of Statin Therapy in Primary Prevention by Opie, Lionel H., MD, DPhil

    “…For primary prevention by a statin, a pre-treatment LDL-C level of 200 mg% (approximately 5 mmol/l) would substantially reduce the 10-year risk of a coronary…”
    Get full text
    Journal Article
  10. 10

    Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection by Lamont, Kim T., Somers, Sarin, Lacerda, Lydia, Opie, Lionel H., Lecour, Sandrine

    Published in Journal of pineal research (01-05-2011)
    “…:  Epidemiological studies suggest that regular moderate consumption of red wine confers cardioprotection but the mechanisms involved in this effect remain…”
    Get full text
    Journal Article
  11. 11

    Early Intravenous Beta-Blockade Before Primary Percutaneous Coronary Intervention Gives Major Benefits, Apparently Without Side Effects by Opie, Lionel H., MD, DPhil

    “…The treated group had few side effects, namely reversible and nonfatal heart block and hypotension. [...]in 2 large studies, beta-blockade had side-effects to…”
    Get full text
    Journal Article
  12. 12

    Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure by TUUNANEN, Helena, ENGBLOM, Erik, KNUUTI, Juhani, NAUM, Alexandru, NAGREN, Kjell, HESSE, Birger, JUHANI AIRAKSINEN, K. E, NUUTILA, Pirjo, IOZZO, Patricia, UKKONEN, Heikki, OPIE, Lionel H

    Published in Circulation (New York, N.Y.) (14-11-2006)
    “…Metabolic modulators that enhance myocardial glucose metabolism by inhibiting free fatty acid (FFA) metabolism may improve cardiac function in heart failure…”
    Get full text
    Journal Article
  13. 13

    HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity by Frias, Miguel A, Pedretti, Sarah, Hacking, Damian, Somers, Sarin, Lacerda, Lydia, Opie, Lionel H, James, Richard W, Lecour, Sandrine

    Published in Atherosclerosis (01-05-2013)
    “…Abstract Objective High density lipoproteins (HDL) protect against ischemia reperfusion injury (IRI). However the precise mechanisms are not clearly…”
    Get full text
    Journal Article
  14. 14

    Interplay Between SAFE and RISK Pathways in Sphingosine-1-Phosphate–Induced Cardioprotection by Somers, Sarin J., Frias, Miguel, Lacerda, Lydia, Opie, Lionel H., Lecour, Sandrine

    Published in Cardiovascular drugs and therapy (01-06-2012)
    “…Purpose We studied the role of two powerful molecular signalling mechanisms involved in the cardioprotective effect of sphingosine-1-phosphate (S1P), a major…”
    Get full text
    Journal Article
  15. 15

    How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis by BRADLEY, Hazel A, WIYSONGE, Charles Shey, VOLMINK, Jimmy A, MAYOSI, Bongani M, OPTE, Lionel H

    Published in Journal of hypertension (01-11-2006)
    “…To quantify the effect of first-line antihypertensive treatment with beta-blockers on mortality, morbidity and withdrawal rates, compared with the other main…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Allopurinol for Heart Failure by Opie, Lionel H., MD, DSc

    “…[...]cytosolic CK then promotes the resynthesis of cytosolic ATP from cytosolic adenosine diphosphate, thus being an essential link in the overall sequence of…”
    Get full text
    Journal Article
  18. 18

    Postconditioning for protection of the infarcting heart by Yellon, Derek M, Opie, Lionel H

    Published in The Lancet (British edition) (11-02-2006)
    “…Coronary heart disease is set to become the leading worldwide cause of death by 2020.1 Acute myocardial infarction is a major cause of such mortality and the…”
    Get full text
    Journal Article
  19. 19

    Beta-blockers for hypertension by Wiysonge, Charles S, Bradley, Hazel A, Volmink, Jimmy, Mayosi, Bongani M, Opie, Lionel H

    Published in Cochrane database of systematic reviews (20-01-2017)
    “…Beta-blockers refer to a mixed group of drugs with diverse pharmacodynamic and pharmacokinetic properties. They have shown long-term beneficial effects on…”
    Get more information
    Journal Article
  20. 20

    Caloric Restriction Models Reverse Metabolic Syndrome by Opie, Lionel H., MD, DPhil, FRCP, FACC

    “…Another example of reversed metabolic syndrome is the acute inhibition of lipolysis by acipimox, which abruptly reduced circulating FFAs in obese patients with…”
    Get full text
    Journal Article